Needham & Company LLC reaffirmed their hold rating on shares of Cognyte Software (NASDAQ:CGNT – Free Report) in a research note published on Tuesday morning, Benzinga reports. Separately, StockNews.com cut shares of Cognyte Software from a strong-buy rating to a buy rating in a research note on Thursday, March 7th. Read Our Latest Research Report […]
Cognyte Software (NASDAQ:CGNT – Get Free Report) had its price objective lifted by equities researchers at Evercore ISI from $5.00 to $7.50 in a research report issued to clients and investors on Wednesday, Benzinga reports. The firm currently has an “in-line” rating on the medical device company’s stock. Evercore ISI’s price objective suggests a potential […]
Legato Capital Management LLC acquired a new position in Cognyte Software Ltd. (NASDAQ:CGNT – Free Report) during the 4th quarter, HoldingsChannel.com reports. The institutional investor acquired 134,407 shares of the medical device company’s stock, valued at approximately $864,000. Other hedge funds and other institutional investors have also modified their holdings of the company. Y.D. More […]
StockNews.com lowered shares of Cognyte Software (NASDAQ:CGNT – Free Report) from a strong-buy rating to a buy rating in a research note published on Thursday morning. Cognyte Software Stock Performance Shares of CGNT opened at $7.30 on Thursday. The firm has a market cap of $502.53 million, a PE ratio of -12.37 and a beta […]
StockNews.com cut shares of Cognyte Software (NASDAQ:CGNT – Free Report) from a buy rating to a hold rating in a report issued on Tuesday morning. Cognyte Software Stock Up 4.8 % Shares of CGNT stock opened at $6.61 on Tuesday. Cognyte Software has a 12 month low of $2.31 and a 12 month high of […]